Real-world zanubrutinib treatment patterns in mantle cell lymphoma (MCL) among US community oncology patients with prior Bruton tyrosine kinase inhibitor (BTKi) therapy.
Authors: Rushir J. Choksi, Gregory A. Maglinte, Xiaoliang Wang, Anupama Vasudevan, Anna Rui, Brandon Wang, Ann Lasn, Lisa Morere, Rhys Williams, Jing-Zhou Hou